Literature DB >> 1656442

A method for production of antibodies to human T-cell receptor beta-chain variable regions.

Y W Choi1, B Kotzin, J Lafferty, J White, M Pigeon, R Kubo, J Kappler, P Marrack.   

Abstract

Mouse T-cell hybridomas bearing human V beta elements were produced by transfection of human/mouse hybrid T-cell receptor beta-chain genes into a mouse T-cell hybridoma lacking an endogenous beta-chain gene. These hybridomas were entirely mouse in origin except for the human V beta region. These cells were used to immunize mice against human V beta elements. Mouse monoclonal antibodies have thus been generated against human V beta 13.1 and -13.2. We expect that the method outlined in this paper will be useful in the production of monoclonal antibodies specific for other human V beta or V alpha elements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656442      PMCID: PMC52507          DOI: 10.1073/pnas.88.19.8357

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Superantigens: mechanism of T-cell stimulation and role in immune responses.

Authors:  A Herman; J W Kappler; P Marrack; A M Pullen
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  A maternally inherited superantigen encoded by a mammary tumour virus.

Authors:  P Marrack; E Kushnir; J Kappler
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

3.  A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.

Authors:  Y Choi; J W Kappler; P Marrack
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

4.  An endogenous retrovirus mediating deletion of alpha beta T cells?

Authors:  D L Woodland; M P Happ; K J Gollob; E Palmer
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

5.  Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus.

Authors:  H Acha-Orbea; A N Shakhov; L Scarpellino; E Kolb; V Müller; A Vessaz-Shaw; R Fuchs; K Blöchlinger; P Rollini; J Billotte
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

6.  Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice.

Authors:  W N Frankel; C Rudy; J M Coffin; B T Huber
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

7.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

8.  In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.

Authors:  B L Rellahan; L A Jones; A M Kruisbeek; A M Fry; L A Matis
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice.

Authors:  Y Kawabe; A Ochi
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  Allelic variations in the human T cell receptor V beta 6.7 gene products.

Authors:  Y Li; P Szabo; M A Robinson; B Dong; D N Posnett
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  13 in total

1.  Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.

Authors:  Natalie Sutkowski; Gang Chen; German Calderon; Brigitte T Huber
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus.

Authors:  C Shimizu; X Li; M Kimura; K Hashimoto; K Sugaya; M Kubo; S Suzuki; T Nakayama
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

3.  A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.

Authors:  F M Batliwalla; B A Bateman; D Serrano; D Murray; S Macphail; V C Maino; J C Ansel; P K Gregersen; C A Armstrong
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

4.  Human Tcrb-V6.10 is a pseudogene with Alu repetitive sequences in the promoter region.

Authors:  Y Li; A Wong; P Szabo; D N Posnett
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.

Authors:  Karolina Malecek; Shi Zhong; Katelyn McGary; Connie Yu; Kevin Huang; Laura A Johnson; Steven A Rosenberg; Michelle Krogsgaard
Journal:  J Immunol Methods       Date:  2013-03-13       Impact factor: 2.303

6.  Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey.

Authors:  Z W Chen; H Yamamoto; D I Watkins; G Levinson; N L Letvin
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions.

Authors:  M F Callan; H T Reyburn; P Bowness; T H Ottenhoff; I Engel; R D Klausner; J I Bell; A McMichael
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins.

Authors:  N Rebai; G Pantaleo; J F Demarest; C Ciurli; H Soudeyns; J W Adelsberger; M Vaccarezza; R E Walker; R P Sekaly; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  An Epstein-Barr virus-associated superantigen.

Authors:  N Sutkowski; T Palkama; C Ciurli; R P Sekaly; D A Thorley-Lawson; B T Huber
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Genetic analysis of low V beta 3 expression in humans.

Authors:  J P Donahue; N S Ricalton; C E Behrendt; C Rittershaus; S Calaman; P Marrack; J W Kappler; B L Kotzin
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.